Theta burst stimulation (TBS) is a non-invasive brain stimulation technique known for modifying human behavior and treating neurological diseases. A group of scientists conducted a systematic review and network meta-analysis to determine the effective TBS protocols for addressing schizophrenia symptoms and cognitive impairment. Their findings suggest that intermittent TBS over the left dorsolateral prefrontal cortex may offer a promising alternative to antipsychotic drug-based treatment.
Read more: New hope for schizophrenia: iTBS over the left DLPFC improves negative and cognitive symptoms
Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why HBV infects humans but not monkeys. This marks a significant medical breakthrough, by identifying new molecular targets for anti-HBV drug development for treating hepatitis B, a disease that places a tremendous burden on the global economy.
Read more: The viral puzzle of why humans are susceptible to hepatitis B virus, but monkeys are not
A new approach could herald a shift in the way we use antibiotics. By attacking the pathogen's unique and hidden metabolic 'vulnerabilities,' researchers offers a new tool in the global challenge to counteract antibiotic resistance and uncover similar combination therapies for other diseases.
Read more: Combo-drug treatment to combat Melioidosis